Comments to authors: Very good summary of current biochemical evidences lacking a holistic view on AD pathogenesis. More than a position paper, it gives the impression of a concise experimental description. This position paper explores the role of Ca2+ stores in the pathogenesis of AD, many in relation to the amyloid hypothesis and presenilin-mediated regulation of calcium intracellular homeostasis. As frequently and in some way abusively, an extraordinary rare situation (that of PS mutation) is taken as regola veritatis of the whole AD pathogenesis. In a first part of their manuscript the authors summarize adequately the evidences supporting the involvement of PS in Ca2+ release form the intracellular stores. The second chapter on soluble Aß effect on synaptic transmission is abruptly introduces and without clear link with the previous one. In particular, they should comment on the effect of soluble amyloid on extracellular Ca influx but also mitochondrial Ca2+ release. An elegant contribution by Park and Chang (2018) shed some light in this complex and largely unknown machinery. The chapter on neural network hyperactivity is very interesting in a really hot topic. However, a rather unilateral approach is used. Aß-related neuronal hyperactivity has been certainly documented yet a tau-related hypoactivity should be mentioned (Buchke et al., Nervenarzt et al., 2016). Most importantly, the biological significance of this hyperactivity is not discussed. Epilepsy is an after all rare complication of severe sporadic AD cases but a recent study by Buchke et al. (2015) showed that the use of anti Aß antibodies fail to revert neuronal hyperactivity despite their positive effect on plaque burden.
